Understanding facilitators and barriers of direct‐acting antiviral therapy for hepatitis C virus infection in prison

Summary Hepatitis C virus ( HCV ) infection is a major public health concern. Globally, 15% of those incarcerated are HCV ‐antibody positive (anti‐ HCV ). Even where HCV treatment is available within prisons, treatment uptake has remained low. This qualitative study was conducted to understand the barriers and facilitators for the delivery of HCV treatment in prisons from the perspectives of prisoners. This is important to inform health...